Results for “”

Entry Author Date Location
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health 07/14/20 Boston
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing 07/08/20 Boston
The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period 07/08/20 National
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck 07/08/20 Boston
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy 07/02/20 San Diego
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing 07/02/20 San Francisco
Annexon Adds On $100M to Advance Antibodies to Treat Neurodegeneration 07/01/20 San Francisco
BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity 07/01/20 Europe
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s 07/01/20 Boston
Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs 07/01/20 San Francisco
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder 06/30/20 San Francisco
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later 06/30/20 Boston
Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage 06/30/20 San Francisco
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug 06/29/20 San Diego
FDA Again Dings Heron’s Opioid Alternative Over “Nonclinical Issues” 06/29/20 San Diego
Page 3 of 1971 « previous page · next page »